Resection and Liver Transplantation for Hepatocellular Carcinoma
The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
Surveillance programs in cirrhotic patients enable the detection of hepatocellular carcinoma (HCC) at early stages, when the tumor is amenable to curative treatments (60% of cases in Japan; 25 to 40% in Europe and the United States). Resection is the mainstay of treatment in noncirrhotic patients and in cirrhotics with well-preserved liver function. In modern series, a perioperative mortality < or = 3% and 5-year survival rates above 50% are expected. Tumor recurrence complicates half of the cases at 3 years, but there is no unquestionable preventive treatment. Liver transplantation provides excellent outcomes applying the Milan criteria (single nodule < or = 5 cm or two or three nodules < or = 3 cm), with 5-year survival rates of 70% and low recurrence rates. Although expansion of selection criteria is appealing, it should be assessed in the setting of prospective well-designed studies. Intention-to-treat analysis has shown that wide extended indications lead to 25% 5-year survival rates. Living donor liver transplantation is having a minor impact in HCC management. Molecular markers are needed to better select the candidates for surgery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In general, European and US guidelines recommend more-restrictive criteria for resection than Asian guidelines7,22–27.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [27]
Citations
Cites
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186 · cited 2×
“, Milan criteria).(19) Knowledge of tumor biology has not improved in parallel with clinical advancement.”
BackgroundSelf-citationClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Self-citationEstimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Self-citationLlovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029 · cited 2×
“Several other treatments have not shown any relevant survival benefit (immunotherapy, internal radiation, tamoxifen, or antiandrogen agents) or are currently under investigation (tyrosine kinase inhibitors, antiangiogenic agents, gene therapy).(35) Table 1 Evidence-Based Benefits in the Treatment of Hepatocellular Car…”
BackgroundSelf-citationLlovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708 · cited 4×
“The BCLC group identified the absence of clinically relevant portal hypertension and normal bilirubin as the key variables to select the best candidates, so-called ChildPugh hyper A patients.(11,57) A hepatic venous pressure gradient > 10 mm Hg was shown to be a predictor of unresolved hepatic decompensation after sur…”
BackgroundInfluentialSelf-citationAmerican Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
Llovet, J. M., Bustamante, J., Castells, A., Vilana, R., Del Carmen Ayuso, M., Sala, M., Brú, C., Rodés, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510290145 · Cited by 1,190 · cited 2×
“6).(7) Treatment of HCC to reduce waiting list dropout has become a priority at most centers (Fig.”
BackgroundSelf-citationPrognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099
Self-citationBelghiti, J., Hiramatsu, K., Benoist, S., Massault, P. P., Sauvanet, A., & Farges, O. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00261-1 · Cited by 1,051
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Jonas, S., Bechstein, W. O., Steinmüller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., & Neuhaus, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23561 · Cited by 894
Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02654-4 · Cited by 847
Poon, R. T.-P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00009 · Cited by 844
An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center
Fong, Y., Sun, R. L., Jarnagin, W., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00005 · Cited by 796
Hepatectomy for Hepatocellular Carcinoma: Toward Zero Hospital Deaths
Fan, S.-T., Lo, C.-M., Liu, C.-L., Lam, C.-M., Yuen, W.-K., Yeung, C., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199903000-00004 · Cited by 728
Arii, S., Yamaoka, Y., Futagawa, S., Inoue, K., Kobayashi, K., Kojiro, M., Makuuchi, M., Nakamura, Y., Okita, K., & Yamada, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20456 · Cited by 725
Simplified Staging for Hepatocellular Carcinoma
Vauthey, J. N., Lauwers, G. Y., Esnaola, N. F., Do, K.-A., Belghiti, J., Mirza, N., Curley, S. A., Ellis, L. M., Regimbeau, J.-M., Rashid, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1527 · Cited by 700
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
IWATSUKI, S., STARZL, T. E., SHEAHAN, D. G., YOKOYAMA, I., DEMETRIS, A. J., TODO, S., TZAKIS, A. G., VAN THIEL, D. H., CARR, B., SELBY, R., et al. (1991) · Annals of Surgery · doi:10.1097/00000658-199109000-00005 · Cited by 669
Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K. T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342402 · Cited by 668
Hepatocellular carcinoma: Diagnosis and treatment
Befeler, A. S., & di Bisceglie, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33411 · Cited by 602
Sangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., Morabito, A., de Franchis, R., & Colombo, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.049 · Cited by 600
Ringe, B., Pichlmayr, R., Wittekind, C., & Tusch, G. (1991) · World Journal of Surgery · doi:10.1007/bf01659064 · Cited by 565
Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating Cirrhosis
BELGHITI, J., PANIS, Y., FAROES, O., BENHAMOU, J. P., & FEKETE, F. (1991) · Annals of Surgery · doi:10.1097/00000658-199108000-00004 · Cited by 562
Liver Transplantation for Hepatocellular Carcinoma
Bismuth, H., Majno, P., & Adam, R. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007120 · Cited by 561
Majno, P. E., Adam, R., Bismuth, H., Castaing, D., Ariche, A., Krissat, J., Perrin, H., & Azoulay, D. (1997) · Annals of Surgery · doi:10.1097/00000658-199712000-00006 · Cited by 513
Iizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
Role of Liver Transplantation in Cancer Therapy
IWATSUKI, S., GORDON, R. D., SHAW, B. W., & STARZL, T. E. (1985) · Annals of Surgery · doi:10.1097/00000658-198510000-00001 · Cited by 496
Mazzaferro, V., Battiston, C., Perrone, S., Pulvirenti, A., Regalia, E., Romito, R., Sarli, D., Schiavo, M., Garbagnati, F., Marchianò, A., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000143301.56154.95 · Cited by 491
Self-citationTorzilli, G. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.9.984 · Cited by 455
Ikai, I., Arii, S., Kojiro, M., Ichida, T., Makuuchi, M., Matsuyama, Y., Nakanuma, Y., Okita, K., Omata, M., Takayasu, K., et al. (2004) · Cancer · doi:10.1002/cncr.20426 · Cited by 451 · cited 4×
“This entity was called H0 by Japanese authors.(18) Therefore, it was proposed that the earliest clinical entity (very early HCC) would include Child-Pugh A patients with carcinoma in situ disease.”
BackgroundInfluentialBurrel, M., Llovet, J. M., Ayuso, C., Iglesias, C., Sala, M., Miquel, R., Caralt, T., Ayuso, J. R., Solé, M., Sanchez, M., et al. (2003) · Hepatology · doi:10.1002/hep.1840380430 · Cited by 451
Self-citationGraziadei, I. W., Sandmueller, H., Waldenberger, P., Koenigsrainer, A., Nachbaur, K., Jaschke, W., Margreiter, R., & Vogel, W. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50106 · Cited by 439
Resection Prior to Liver Transplantation for Hepatocellular Carcinoma
Belghiti, J., Cortes, A., Abdalla, E. K., Régimbeau, J.-M., Prakash, K., Durand, F., Sommacale, D., Dondero, F., Lesurtel, M., Sauvanet, A., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000098621.74851.65 · Cited by 415
Lau, W., Leung, T., Ho, S., Chan, M., Machin, D., Lau, J., Chan, A., Yeo, W., Mok, T., Yu, S., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06475-7 · Cited by 409
Roayaie, S., Frischer, J. S., Emre, S. H., Fishbein, T. M., Sheiner, P. A., Sung, M., Miller, C. M., & Schwartz, M. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00012 · Cited by 390
Self-citationCriteria for safe hepatic resection
Miyagawa, S., Makuuchi, M., Kawasaki, S., & Kakazu, T. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80227-x · Cited by 387
Todo, S., & Furukawa, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000137129.98894.42 · Cited by 380 · cited 1×
“2%, respectively) (Table 2).(34) At this point, there is no evidence that the timing or severity of recurrence of HCC is different after LDLT versus deceased donor transplantation, despite theoretical concerns related to stimulation of residual tumor cells by growth factors related to hepatic regeneration.”
BackgroundPatterns of Recurrence After Initial Treatment in Patients With Small Hepatocellular Carcinoma
Kumada, T., Nakano, S., Takeda, I., Sugiyama, K., Osada, T., Kiriyama, S., Sone, Y., Toyoda, H., Shimada, S., Takahashi, M., et al. (1997) · Hepatology · doi:10.1002/hep.510250116 · Cited by 378
Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection
Izumi, R., Shimizu, K., II, T., Yagi, M., Matsui, O., Nonomura, A., & Miyazaki, I. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90707-2 · Cited by 371
Ikeda, K., Arase, Y., Saitoh, S., Kobayashi, M., Suzuki, Y., Suzuki, F., Tsubota, A., Chayama, K., Murashima, N., & Kumada, H. (2000) · Hepatology · doi:10.1053/jhep.2000.9409 · Cited by 354
Majno, P. E., Sarasin, F. P., Mentha, G., & Hadengue, A. (2000) · Hepatology · doi:10.1053/he.2000.5763 · Cited by 326
Cillo, U., Vitale, A., Bassanello, M., Boccagni, P., Brolese, A., Zanus, G., Burra, P., Fagiuoli, S., Farinati, F., Rugge, M., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000109146.72827.76 · Cited by 315 · cited 1×
“For example, a favorable post-transplantation prognosis has been reported for single well-differentiated HCCs exceeding Milan criteria.(30) Genetic data have been incorporated to refine the clinical decision model to define predictors of HCC recurrence.”
BackgroundOne Hundred Nine Living Donor Liver Transplants in Adults and Children: A Single-Center Experience
Miller, C. M., Gondolesi, G. E., Florman, S., Matsumoto, C., Muñoz, L., Yoshizumi, T., Artis, T., Fishbein, T. M., Sheiner, P. A., Kim-Schluger, L., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00004 · Cited by 312
Self-citationExperience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma
Zhou, X.-D., Tang, Z.-Y., Yang, B.-H., Lin, Z.-Y., Ma, Z.-C., Ye, S.-L., Wu, Z.-Q., Fan, J., Qin, L.-X., & Zheng, B.-H. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1479::aid-cncr1155>3.0.co;2-0 · Cited by 302 · cited 1×
“Multinodular tumors have an increased tendency to recur because most of them represent disseminated disease.(13,18) In the largest series ever reported, the 5-year survival after resection of single tumors was 57% and for three or more nodules was 26%.”
BackgroundRisk factors for intrahepatic recurrence in human small hepatocellular carcinoma
Adachi, E., Maeda, T., Matsumata, T., Shirabe, K., Kinukawa, N., Sugimachi, K., & Tsuneyoshi, M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90450-6 · Cited by 272
Right lobe living donor liver transplantation: A review
Marcos, A. (2000) · Liver Transplantation · doi:10.1002/lt.500060117 · Cited by 272
Yao, F. Y., Bass, N. M., Nikolai, B., Merriman, R., Davern, T. J., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50147 · Cited by 271
Predictive factors for postoperative recurrence of hepatocellular carcinoma
Okada, S., Shimada, K., Yamamoto, J., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., & Hirohashi, S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90419-7 · Cited by 268
Bralet, M.-P., Régimbeau, J.-M., Pineau, P., Dubois, S., Loas, G., Degos, F., Valla, D., Belghiti, J., Degott, C., & Terris, B. (2000) · Hepatology · doi:10.1053/jhep.2000.9033 · Cited by 249
Chen, Y.-J., Yeh, S.-H., Chen, J.-T., Wu, C.-C., Hsu, M.-T., Tsai, S.-F., Chen, P.-J., & Lin, C.-H. (2000) · Gastroenterology · doi:10.1053/gast.2000.9373 · Cited by 229
Hepatocellular carcinoma: Current surgical management
Song, T.-J., Wai Kit Ip, E., & Fong, Y. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.039 · Cited by 228
Villa, E., Moles, A., Ferretti, I., Buttafoco, P., Grottola, A., Del Buono, M., De Santis, M., & Manenti, F. (2000) · Hepatology · doi:10.1053/jhep.2000.9603 · Cited by 224
Shetty, K., Timmins, K., Brensinger, C., Furth, E. E., Rattan, S., Sun, W., Rosen, M., Soulen, M., Shaked, A., Reddy, R. K., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20140 · Cited by 219
Wu, C.-C., Ho, Y.-Z., Ho, W. L., Wu, T.-C., Liu, T.-J., & P'Eng, F.-K. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800820141 · Cited by 218
Gondolesi, G. E., Roayaie, S., Muñoz, L., Kim-Schluger, L., Schiano, T., Fishbein, T. M., Emre, S., Miller, C. M., & Schwartz, M. E. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000109022.32391.eb · Cited by 206 · cited 1×
“The first study reported an overall 3year survival rate of 54%,(32) whereas the Mount Sinai study showed a 3-year survival of 86% of patients within Milan criteria and of 42% for patients with expanded criteria (Table 2).(33) In Japan, a survey including 316 patients reported better 3-year survival and lower recurrenc…”
BackgroundSelf-citationStone, M. J., Klintmalm, G. B. G., Polter, D., Husberg, B. S., Mennel, R. G., Ramsay, M. A. E., Flemens, E. E., & Goldstein, R. M. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90852-4 · Cited by 196
Living-donor liver transplantation for hepatocellular carcinoma
Kaihara, S., Kiuchi, T., Ueda, M., Oike, F., Fujimoto, Y., Ogawa, K., Kozaki, K., & Tanaka, K. (2003) · Transplantation · doi:10.1097/01.tp.0000047029.02806.16 · Cited by 185
Focus on dysplastic nodules and early hepatocellular carcinoma: An Eastern point of view
Kojiro, M. (2004) · Liver Transplantation · doi:10.1002/lt.20042 · Cited by 171
The surgical approach to HCC: Our progress and results in Japan
Makuuchi, M., & Sano, K. (2004) · Liver Transplantation · doi:10.1002/lt.20044 · Cited by 166 · cited 3×
“To overcome this limitation, some groups are applying preoperative portal vein embolization of the branches supplying the portion of the liver to be resected, particularly if the remnant volume is below 40% in a noncirrhotic liver or below 60% in a cirrhotic liver with an ICG15 exceeding 20%.(42) The effectiveness of…”
BackgroundInfluentialAdjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular Carcinoma
Olthoff, K. M., Rosove, M. H., Shackleton, C. R., Imagawa, D. K., Farmer, D. G., Northcross, P., Pakrasi, A. L., Martin, P. B., Goldstein, L. I., Shaked, A. A., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00012 · Cited by 156
Russo, C. L., Pellarin, M., Tingby, O., Bollen, A. W., Lamborn, K. R., Mohapatra, G., Collins, V. P., & Feuerstein, B. G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<316::aid-cncr16>3.0.co;2-t · Cited by 153
Oldhafer, K. J., Chavan, A., Frühauf, N. R., Flemming, P., Schlitt, H. J., Kubicka, S., Nashan, B., Weimann, A., Raab, R., Manns, M. P., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80123-2 · Cited by 152
Izumi, R., Shimizu, K., IYOBE, T., Ii, T., Yagi, M., Matsui, O., Nonomura, A., & Miyazaki, I. (1994) · Hepatology · doi:10.1002/hep.1840200205 · Cited by 131
Lin, S., Lin, C., Hsu, C., Tai, D., Sheen, I., Lin, D., & Liaw, Y. (2004) · Cancer · doi:10.1002/cncr.20004 · Cited by 128
Gaglio, P. J., Malireddy, S. R., Levitt, B. S., Lapointe-Rudow, D., Lefkowitch, J. H., Kinkhabwala, M. M., Russo, M. W., Emond, J. C., & Brown, R. S. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50211 · Cited by 128
Molmenti, E. P., & Klintmalm, G. B. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34879 · Cited by 123 · cited 3×
“The model relies on number and size of the nodules identified by radiological preoperative staging (R)(19,26,27,104) or pathological staging (P).(22,28,29) Outcomes reflect published data or expected survival in prospective studies (E).”
BackgroundMethodRoayaie, S., Ben‐Haim, M., Emre, S., Fishbein, T., Sheiner, P. A., Miller, C. M., & Schwartz, M. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0764-8 · Cited by 109
Self-citationBoucher, É., Corbinais, S., Rolland, Y., Bourguet, P., Guyader, D., Boudjéma, K., Meunier, B., & Raoul, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50473 · Cited by 106
Finkelstein, S. D., Marsh, W. J., Demetris, A. J., Swalsky, P. A., Sasatomi, E., Bonham, C. A., Subotin, M., & Dvorchik, I. (2003) · Hepatology · doi:10.1053/jhep.2003.50134 · Cited by 105
Prognostic Prediction in Patients with Hepatocellular Carcinoma
Sala, M., Forner, A., Varela, M., & Bruix, J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871197 · Cited by 87
Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation
Rizzi, P. M., Kane, P. A., Ryder, S. D., Ramage, J. K., Gane, E. J., Tan, K. C., Portmann, B. C., Karani, J. B., & Williams, R. L. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90545-2 · Cited by 81
Liver (Including Intrahepatic Bile Ducts)
Greene, F. L., Ph.D., C.T.R., A. G. F., et al. (2006) · Springer eBooks · doi:10.1007/0-387-33126-3_14 · Cited by 80
Safe donor hepatectomy for living related liver transplantation
Sugawara, Y., Makuuchi, M., Takayama, T., Imamura, H., Kaneko, J., & Ohkubo, T. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.29761 · Cited by 79
Surgical Treatment of Hepatocellular Cancer in the Era of Hepatic Transplantation
Carlis, L. G. D., Giacomoni, A., Pirotta, V., Lauterio, A., Slim, A. O., Sammartino, C., Cardillo, M., & Forti, D. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00140-6 · Cited by 79
Ono, T., Nagasue, N., Kohno, H., Hayashi, T., Uchida, M., YUKAYA, H., & Yamanoi, A. (1997) · Seminars in Oncology · Cited by 76
Bozorgzadeh, A., Jain, A., Ryan, C., Ornt, D. B., Zand, M. S., Mantry, P., Lansing, K., & Orloff, M. S. (2004) · Transplantation · doi:10.1097/01.tp.0000122142.00818.9e · Cited by 70
IHPBA concordant classification of primary liver cancer: working group report
Makuuchi, M., Belghiti, J., Belli, G., Fan, S.-T., Lau, J. W. Y., Ringe, B., Strasberg, S. M., Vauthey, J., Yamaoka, Y., & Yamasaki, S. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s10534-002-0808-6 · Cited by 69
Torzilli, G., Olivari, N., Moroni, E., Fabbro, D. D., Gambetti, A., Leoni, P., Montorsi, M., & Makuuchi, M. (2004) · Liver Transplantation · doi:10.1002/lt.20050 · Cited by 62
Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease
Kianmanesh, R., Regimbeau, J. M., & Belghiti, J. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00090-x · Cited by 57
Kohno, H., Nagasue, N., Hayashi, T., Yamanoi, A., Uchida, M., Ono, T., YUKAYA, H., Kimura, N., & Nakamura, T. (1996) · PubMed · Cited by 55
Ueno, S., Tanabe, G., Yoshida, A., Yoshidome, S., Takao, S., & Aikou, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<248::aid-cncr8>3.0.co;2-1 · Cited by 43
Izumi, M., Nakanishi, Y., Takayama, K., Kimotsuki, K., Inoue, K., Wataya, H., Minami, T., & Hara, N. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1451::aid-cncr1152>3.0.co;2-z · Cited by 42
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
Garcı́a-Retortillo, M., & Forns, X. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.04.023 · Cited by 39
Calne, R. Y. (1987) · Gut · doi:10.1136/gut.28.6.778 · Cited by 30
Transplantation for primary liver cancer
Esquivel, C. O., Iwatsuki, S., Gordon, R., & Starzl, T. E. (1986) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 6
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“Some centers have reported zero peri-operative mortality [176,183].”
BackgroundInfluentialForner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Self-citationEl-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Self-citationMazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Self-citation
Metadata
- Authors
- Llovet, J. M., Schwartz, M., & Mazzaferro, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Mount Sinai Hospital (US)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005-05
- Volume
- 25
- Issue
- 02
- Pages
- 181-200
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W1990073288
- Cited by
- 879
- References
- 84
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 23 · 2023: 18 · 2022: 28 · 2021: 32 · 2020: 44 · 2019: 52 · 2018: 48 · 2017: 51 · 2016: 60 · 2015: 66 · 2014: 70 · 2013: 66 · 2012: 47
- FWCI
- 26.04
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK060498, K24 DK 60498-01)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, hepatectomy, liver transplantation, Milan criteria, liver cirrhosis, tumor recurrence, extended indications, living donor liver transplantation, molecular markers, surgical selection, perioperative mortality, survival outcomes
- MeSH terms
- Hepatectomy, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Survival Analysis, Liver Transplantation, Chemoembolization, Therapeutic, Chemotherapy, Adjuvant, Patient Selection, Living Donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.